DCVC, once Data Collective, is a deep-tech venture firm whose DCVC Bio arm backs computational biology and cancer diagnostics companies.
DCVC is a venture capital firm founded in 2011 that invests in deep technology, with a dedicated DCVC Bio strategy for computational and engineering approaches to biology, agriculture and health. Its oncology investments have centred on data-heavy diagnostics and platform companies. Offices in Palo Alto and San Francisco; portfolio links in OnCo are derived from the startup records that name it.
| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Noetik South San Francisco, CA, US | Startup | ai software | Series A 2024, $40M | |
| Radionetics Oncology San Diego, CA, US | Startup | radiopharma | Series A 2024, $53M | |
| Sidewinder Therapeutics San Diego, CA, US | Startup | biotech | Non-small-cell lung cancerHead and neck squamous cell carcinomaColorectal cancer | Series B 2026, $137M |
| Solu Therapeutics Boston, MA, US | Startup | biotech | Chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasmsAcute myeloid leukaemia | Series A 2025, $41M |
| Valar Labs Palo Alto, CA, US | Startup | ai software | Bladder & urothelial cancerProstate cancerPancreatic ductal adenocarcinoma | Series A 2024, $22M |
Shares Radionetics Oncology, Sidewinder Therapeutics and the tag vc.
Shares Solu Therapeutics, Sidewinder Therapeutics and the tag vc.
Shares Radionetics Oncology and the tag vc.
Shares Solu Therapeutics and the tag vc.
Shares Valar Labs and the tag vc.
Shares Noetik and the tag vc.
Shares Noetik and the tag vc.
Shares Sidewinder Therapeutics and the tag vc.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/